Overcoming Malignant Glioma Therapeutic Challenges: Nanocarrier-Mediated Delivery of Immune Checkpoint Blockers via Nasal Route

Abstract

Malignant glioma represents a prevailing malignancy within both paediatric and adult populations, necessitating advanced therapeutic interventions. Traditional therapeutic avenues encompassing surgical resection, radiotherapy, and chemotherapy have yielded unsatisfactory clinical outcomes